Kodak’s stock price has gone on quite a roller coaster ride over the past week after the company announced a $765M US loan to pivot into generic drug production. But it’s not just the price people are talking about — unusual trading activity and a stock option grant to Kodak’s CEO are also making headlines. […]
Kodak’s stock price has gone on quite a roller coaster ride over the past week after the company announced a $765M US loan to pivot into generic drug production. But it’s not just the price people are talking about — unusual trading activity and a stock option grant to Kodak’s CEO are also making headlines. […]
Share this Article
Recommended